Get the Stockscreener App
0.93
1.59%
-0.015
Clearside Biomedical Inc Stock (CLSD) Forecast
The Clearside Biomedical Inc (CLSD) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.0932, representing a +232.60% increase from the current price of $0.93. The highest analyst price target is $4.2007, and the lowest is $1.9857.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CLSD Price Target
Average 2.6883
(+189.06% Upside)
Is Clearside Biomedical Inc (CLSD) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.27 | Neutral |
| STOCH(9,6) | 36.53 | Neutral |
| STOCHRSI(14) | 62.65 | Neutral |
| MACD(12,26) | -0.015 | Buy |
| ADX(14) | 11.60 | Neutral |
| William %R | -62.50 | Neutral |
| CCI(14) | -0.0237 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9313
Sell
|
0.9332
Sell
|
| MA20 |
0.9441
Sell
|
0.9423
Sell
|
| MA50 |
0.9822
Sell
|
0.9836
Sell
|
| MA100 |
1.0865
Sell
|
1.0413
Sell
|
| MA200 |
1.1414
Sell
|
1.0941
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CLSD could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on CLSD, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.27 indicates that CLSD is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 36.53 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 62.65 indicates that CLSD is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 11.6 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -0.0237 indicates that CLSD is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CLSD price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Clearside Biomedical Inc financial reports and earnings history, Clearside Biomedical Inc (CLSD) stock could reach $1.46 by 2030, $1.716 by 2040 and $3.2383 by 2050. See the projected annual prices until 2050 of the Clearside Biomedical Inc stock below:
- Clearside Biomedical Inc (CLSD) is expected to reach an average price of $1.1685 in 2035, with a high prediction of $1.3485 and a low estimate of $0.8434. This indicates an $25.65% rise from the last recorded price of $0.93.
- Clearside Biomedical Inc (CLSD) stock is projected to chart a bullish course in 2040, with an average price target of $1.2461, representing an $33.99% surge from its current level. The forecast ranges from a conservative $1.1479 to a sky-high $1.716.
- Our analysts predict Clearside Biomedical Inc (CLSD) to jump 77.71% by 2045, soaring from $1.3127 to an average price of $1.6527, potentially reaching $1.7327. While $1.3127 is the low estimate, the potential upside is significant.
- Clearside Biomedical Inc (CLSD) stock is expected to climb by 2050, reaching an average of $3.0083, a $223.47% jump from its current level. However, a wide range of estimates exists, with high and low targets of $3.2383 and $1.6982, respectively, highlighting the market's uncertainty.
Clearside Biomedical Inc Stock (CLSD) Year by Year Forecast
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2025
Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.6883 in 2025, with a high prediction of $4.2007 and a low estimate of $1.1759. This indicates an +189.06% rise from the last recorded price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $2.2557 | $1.9857 | $4.2007 | +142.55% |
| April, 2025 | $1.7557 | $1.1759 | $3.3758 | +88.79% |
| May, 2025 | $2.2287 | $1.5356 | $2.6159 | +139.64% |
| June, 2025 | $2.0559 | $1.8447 | $2.4259 | +121.07% |
| July, 2025 | $2.046 | $1.886 | $2.626 | +120.00% |
| August, 2025 | $1.8161 | $1.7361 | $2.1361 | +95.28% |
| September, 2025 | $1.8362 | $1.6661 | $2.1261 | +97.44% |
| October, 2025 | $1.6262 | $1.5662 | $2.0162 | +74.86% |
| November, 2025 | $1.6163 | $1.5063 | $1.9163 | +73.80% |
| December, 2025 | $1.4264 | $1.3264 | $1.6763 | +53.37% |
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2026
The predicted value for Clearside Biomedical Inc (CLSD) in 2026 is set at an average of $4.5768. Estimates vary from a peak of $7.8071 to a trough of $1.3464, indicating an +392.12% surge from the present price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.0264 | $1.3464 | $2.1564 | +117.90% |
| February, 2026 | $2.1165 | $1.7565 | $2.4765 | +127.58% |
| March, 2026 | $4.0866 | $1.9965 | $4.3766 | +339.42% |
| April, 2026 | $3.9266 | $3.0466 | $4.6066 | +322.22% |
| May, 2026 | $2.8167 | $2.7367 | $4.3267 | +202.87% |
| June, 2026 | $2.7368 | $2.2867 | $2.8767 | +194.28% |
| July, 2026 | $2.4569 | $2.3369 | $3.3768 | +164.18% |
| August, 2026 | $3.0869 | $2.3069 | $3.3469 | +231.93% |
| September, 2026 | $5.587 | $3.0869 | $7.367 | +500.75% |
| October, 2026 | $5.2871 | $4.647 | $6.207 | +468.50% |
| November, 2026 | $6.9671 | $4.9371 | $7.8071 | +649.15% |
| December, 2026 | $6.0572 | $5.8772 | $7.4172 | +551.31% |
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Clearside Biomedical Inc (CLSD) is $3.8175, with a high forecast of $6.2971 and a low forecast of $1.3379. This indicates an +310.49% increase from the last price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.8073 | $4.8972 | $6.2971 | +524.44% |
| February, 2027 | $4.4473 | $4.4273 | $6.1973 | +378.21% |
| March, 2027 | $3.0174 | $2.7474 | $4.4774 | +224.45% |
| April, 2027 | $2.3075 | $2.2475 | $3.0874 | +148.12% |
| May, 2027 | $1.8675 | $1.7775 | $2.3475 | +100.81% |
| June, 2027 | $1.4676 | $1.4076 | $1.9286 | +57.81% |
| July, 2027 | $2.3677 | $1.3876 | $2.9277 | +154.59% |
| August, 2027 | $1.6778 | $1.6578 | $2.6177 | +80.40% |
| September, 2027 | $1.4178 | $1.3478 | $1.9578 | +52.46% |
| October, 2027 | $1.5379 | $1.3379 | $1.5779 | +65.37% |
| November, 2027 | $1.808 | $1.448 | $1.808 | +94.40% |
| December, 2027 | $1.668 | $1.518 | $1.933 | +79.36% |
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2028
In 2028, Clearside Biomedical Inc (CLSD) is projected to reach an average price of $1.4536, with a high projection of $1.9285 and a low estimate of $0.9787. This indicates an +56.30% rise from the last price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.4381 | $1.3881 | $1.6781 | +54.64% |
| February, 2028 | $1.2082 | $1.0782 | $1.4681 | +29.91% |
| March, 2028 | $1.2183 | $1.0982 | $1.4982 | +30.99% |
| April, 2028 | $1.2583 | $1.1883 | $1.6883 | +35.30% |
| May, 2028 | $1.2184 | $1.0584 | $1.3584 | +31.01% |
| June, 2028 | $1.5785 | $1.1184 | $1.8984 | +69.73% |
| July, 2028 | $1.3985 | $1.361 | $1.9285 | +50.38% |
| August, 2028 | $1.1586 | $1.1386 | $1.4986 | +24.58% |
| September, 2028 | $1.3187 | $0.9787 | $1.5587 | +41.79% |
| October, 2028 | $1.0887 | $0.9905 | $1.3287 | +17.07% |
| November, 2028 | $1.2288 | $1.0788 | $1.2687 | +32.13% |
| December, 2028 | $1.1989 | $1.1789 | $1.6189 | +28.91% |
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2029
The 2029 price forecast for Clearside Biomedical Inc Stock (CLSD) is $1.4644 on average, with a high prediction of $2.1996 and a low estimate of $0.7293. This represents an +57.46% increase from the previous price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.249 | $1.1089 | $1.3788 | +34.30% |
| February, 2029 | $1.019 | $0.999 | $1.269 | +9.57% |
| March, 2029 | $0.9041 | $0.9041 | $1.039 | -2.79% |
| April, 2029 | $0.9401 | $0.8991 | $0.9891 | +1.09% |
| May, 2029 | $1.0475 | $0.7293 | $1.2692 | +12.64% |
| June, 2029 | $1.1093 | $0.9578 | $1.1393 | +19.28% |
| July, 2029 | $1.2494 | $1.0036 | $1.3393 | +34.34% |
| August, 2029 | $1.3294 | $1.1794 | $1.6144 | +42.95% |
| September, 2029 | $1.4395 | $1.2495 | $1.5395 | +54.78% |
| October, 2029 | $1.7896 | $1.3795 | $2.1996 | +92.43% |
| November, 2029 | $1.3896 | $1.1796 | $1.8596 | +49.42% |
| December, 2029 | $1.345 | $1.31 | $1.5597 | +44.62% |
Clearside Biomedical Inc Stock (CLSD) Price Forecast for 2030
Clearside Biomedical Inc Stock (CLSD) is expected to reach an average price of $2.4955 in 2030, with a high forecast of $4.2764 and a low forecast of $0.7145. This signifies an +168.33% surge from the last price of $0.93.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1952 | $1.1026 | $1.46 | +28.51% |
| February, 2030 | $1.3503 | $1.1103 | $1.3703 | +45.19% |
| March, 2030 | $1.2154 | $1.2004 | $1.3503 | +30.69% |
| April, 2030 | $0.7572 | $0.7145 | $1.5404 | -18.58% |
| May, 2030 | $0.7807 | $0.7206 | $1.0956 | -16.05% |
| June, 2030 | $1.0758 | $0.7507 | $1.2108 | +15.68% |
| July, 2030 | $1.301 | $1.0758 | $1.5315 | +39.89% |
| August, 2030 | $2.5611 | $1.3113 | $3.0011 | +175.39% |
| September, 2030 | $2.3613 | $1.9334 | $4.1012 | +153.91% |
| October, 2030 | $2.6564 | $2.1013 | $4.2764 | +185.64% |
| November, 2030 | $2.1415 | $1.9218 | $3.4515 | +130.27% |
| December, 2030 | $1.7217 | $1.2517 | $2.1216 | +85.13% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):